Controlled decorin delivery from injectable microgels promotes scarless vocal fold repair
Preprint
Abstract
Vocal fold (VF) scarring is a leading cause of poor voice, yet no therapies exist to prevent its progression. Current treatments, such as intracordal steroid injections, offer limited efficacy and carry significant off-target toxicities. To identify targeted anti-scarring strategies, we performed transcriptomics of human VF myofibroblasts, the cellular drivers of VF scarring, and identified the proteoglycan decorin (DCN) as downregulated in activated myofibroblasts. We also show a time-dependent decrease in DCN during fibrotic wound healing in a preclinical rat model of VF scarring. Administration of DCN suppressed VF myofibroblast activation by reducing pro-fibrotic gene expression, α-smooth muscle actin (α-SMA) levels, and cell contractility. DCN was encapsulated in hyaluronic acid microgels for sustained protein release for 3–4 weeks. In a rat model of VF scarring, DCN-loaded microgels prevented hallmark features of scarring, including collagen deposition and myofibroblast activation. These findings highlight DCN as a promising therapeutic and provide a sustained delivery platform with translational potential against VF scarring. Teaser Controlled decorin drug delivery from hyaluronic acid microgels attenuates myofibroblast activation to prevent vocal fold scarring, offering a translational strategy to improve post-injury voice outcomes.Keywords
Funding Information
- National Science Foundation (DGE 1845298)
This publication has 63 references indexed in Scilit:
- Duration of Clinical Response After In‐Office Steroid Injection for Vocal Fold ScarThe Laryngoscope, 2023
- Variations in Practices and Preferences of Vocal Fold Injection Materials: A National SurveyThe Laryngoscope, 2022
- The Role of Cytokines in Modulating Vocal Fold Fibrosis: A Contemporary ReviewThe Laryngoscope, 2020
- Patient‐defined duration of benefit from juvederm (hyaluronic acid) used in injection laryngoplastyThe Laryngoscope, 2019
- Cellular source and proinflammatory roles of high-mobility group box 1 in surgically injured rat vocal foldsThe Laryngoscope, 2016
- The role of Smad3 in the fibrotic phenotype in human vocal fold fibroblastsThe Laryngoscope, 2015
- Smad3: An emerging target for vocal fold fibrosisThe Laryngoscope, 2014
- Direct health care costs of laryngeal diseases and disordersThe Laryngoscope, 2012
- Self‐reported impact of dysphonia in a primary care population: An epidemiological studyThe Laryngoscope, 2010
- Decorin regulates assembly of collagen fibrils and acquisition of biomechanical properties during tendon developmentJournal of Cellular Biochemistry, 2006